Samuel Karlin died Dec. 18 at age 83. He was a professor emeritus of mathematics at Stanford University. Among other achievements, Karlin made fundamental contributions to biomolecular sequence analysis. Born in Yanovo, Poland, he earned a PhD from Princeton University. Before coming to Stanford, he was on the faculty at Caltech from 1948 to 1956.
John West, John Stuelpnagel, Christian Henry, David Smith, Samuel Karlin
John West, senior vice president and general manager of Illumina’s sequencing business, will resign from the company, effective Feb. 1. He is the former CEO of Solexa. Effective immediately, Christian Henry, Illumina’s senior vice president and chief financial officer, will take on the role of acting general manager of the sequencing business.
John Stuelpnagel, senior vice president, chief operating officer, and general manager for Illumina’s array business, has decided to move to a part-time position as of April 1. He will work on “key projects” as an Illumina Fellow, according to the company. He will also step down from Illumina's board of directors.
David Smith has become vice president of operations, a new position, at Codon Devices, the company said last week. He will oversee Codon Devices' manufacturing, process development, quality, and operations organizations.
Most recently, Smith was vice president of manufacturing at 454 Life Sciences. Prior to that, he was vice president of manufacturing technology at Affymetrix. Smith holds a PhD in chemistry from the University of Arizona and a BSc in chemistry from North Central College.